Soleus Capital Management, L.P. - CATABASIS PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Soleus Capital Management, L.P. ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2021$1,635,000
-27.0%
775,0000.0%0.25%
-37.9%
Q1 2021$2,240,000775,0000.40%
Other shareholders

There were no reported owners of CATABASIS PHARMACEUTICALS IN in Q3 2023.

NameSharesValueWeighting ↓
View complete list of CATABASIS PHARMACEUTICALS IN shareholders